Association of treponemal chemiluminescent immunoassay signal intensity with TPPA reactivity in reverse sequence syphilis screening
Year: 2026
Type: article
Study design: Observational Study
Abstract: Reverse sequence screening for syphilis using treponemal chemiluminescent immunoassays (Tp-CIAs) is widely used in clinical laboratories; however, interpretation is typically based on binary cutoff values, and the clinical value of signal intensity remains underutilized. We conducted a retrospective diagnostic performance accuracy study including 1,827 individuals undergoing routine screening to evaluate the clinical utility of the Tp-CIA cutoff index (COI) as a continuous variable, using the TPPA as the reference standard. ROC analysis was performed to determine the optimal cutoff, and associations between COI values and TPPA reactivity were assessed. Tp-CIA demonstrated excellent discrimination of TPPA reactivity (area under the curve 0.992). COI values showed a strong monotonic association with TPPA reactivity (Spearman r s = 0.855), increasing from 2.5% at a COI <1 to 99.8% at a COI ≥30. An exploratory cutoff of COI = 3.25 increased specificity from 88.6% to 96.4%, with a corresponding decrease in sensitivity from 99.1% to 95.9%, compared with the manufacturer-recommended cutoff of 1.0. Discordant results (3.9%) were largely confined to low COI values, whereas high COI values were strongly associated with TPPA reactivity. Diagnostic performance remained consistent across HIV subgroups. Among individuals with concurrent non-treponemal testing, COI values were positively correlated with ordered rapid plasma reagin ( r s = 0.637) and toluidine red unheated serum test ( r s = 0.705) titer levels. These findings demonstrate that, within the analytical conditions of this study, higher assay-specific COI values were associated with a greater likelihood of TPPA reactivity. COI-based interpretation should remain supplementary to established confirmatory testing and clinical assessment; exploratory threshold requires independent analytical and clinical validation. IMPORTANCE Syphilis remains a growing global public health concern, and reverse sequence screening using Treponema pallidum chemiluminescent immunoassay (Tp-CIA) is widely adopted. Although these assays are interpreted qualitatively using manufacturer-defined cutoffs, the underlying signal intensity varies across specimens. In this study cohort, increasing Tp-CIA cutoff index (COI) values were associated with an increasing observed proportion of TPPA-reactive results. This association was assay- and cohort-specific and should be interpreted descriptively. COI should not replace established confirmatory testing, quantitative non-treponemal testing, or clinical assessment, and its potential supplementary value requires independent analytical and clinical validation.
Source: Microbiology Spectrum
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,500
Funder: Yuhan
OpenAlex ID: W7235182749
